Gland Pharma Ltd (GLAND)

Company profile

Sector

Pharmaceuticals

Industry

Pharmaceuticals & Biotechnology

Market cap (₹ Cr)

46,509.56

Gland Pharma Ltd. manufactures pharmaceutical ingredients and injectable formulations. The company is headquartered in Hyderabad, Telangana. The company went IPO on 2020-11-20. The firm specializes in complex injectables and is engaged in the sterile injectables, oncology, and ophthalmology segments. The firm provides contract development, own development, dossier preparation and filing, technology transfer and manufacturing across a variety of delivery systems. Its products are available in liquid vials, lyophilized vials, pre-filled syringes, ampoules, bags, and drops. Its key molecules include Heparin Sodium Injection, Enoxaparin Sodium Injection, Rocuronium Bromide Injection, Daptomycin Injection, among others. Its therapeutic products categories include Anti Malarials, Anti-Infectives, Anti-Neoplastics, Blood Related, Cardiac, Gastrointestinal, Gynaecological, Hormones, Neuro / Cns, Ophthal / Otologicals, Pain/Analgesics, Respiratory and Vitamins / Minerals / Nutrients. Its products are sold across various countries, which include United States, Europe, Canada, and others.

Source: finedge · as of 2026-09-29

Price, last year

Last close (₹): 2,850.4

Source: quantro_screener_metrics_job · as of 2026-10-22

Key figures

P/E

45.72

52-week high

3,171

52-week low

1,573.6

Revenue CAGR, 3 years (%)

21.06

Revenue CAGR, 5 years (%)

13.18

EPS CAGR, 3 years (%)

9.55

EPS CAGR, 5 years (%)

0.46

Source: quantro_screener_metrics_job · as of 2026-10-23

Annual summary

Source: finedge · as of 2026-07-21

Shareholding and promoter pledge

Promoter

51.83%

FII

7.3%

DII

33.35%

Public

7.52%

Promoter shares pledged

0%

Source: finedge · as of 2026-03-31

Similar companies

• IPCA Laboratories Ltd₹ 45,531.03 Cr
• GlaxoSmithKline Pharmaceuticals Ltd₹ 45,206 Cr
• Ajanta Pharma Ltd₹ 42,842.3 Cr
• JB Chemicals & Pharmaceuticals Ltd₹ 38,730.77 Cr
• Emcure Pharmaceuticals Ltd₹ 36,550.41 Cr
• Wockhardt Ltd₹ 33,525.38 Cr

Source: quantro_company_profiles · as of 2026-10-23

Frequently asked questions

What does Gland Pharma Ltd do?

Gland Pharma Ltd. manufactures pharmaceutical ingredients and injectable formulations. The company is headquartered in Hyderabad, Telangana. The company went IPO on 2020-11-20. The firm specializes in complex injectables and is engaged in the sterile injectables, oncology, and ophthalmology segments. The firm provides contract development, own development, dossier preparation and filing, technology transfer and manufacturing across a variety of delivery systems. Its products are available in liquid vials, lyophilized vials, pre-filled syringes, ampoules, bags, and drops. Its key molecules include Heparin Sodium Injection, Enoxaparin Sodium Injection, Rocuronium Bromide Injection, Daptomycin Injection, among others. Its therapeutic products categories include Anti Malarials, Anti-Infectives, Anti-Neoplastics, Blood Related, Cardiac, Gastrointestinal, Gynaecological, Hormones, Neuro / Cns, Ophthal / Otologicals, Pain/Analgesics, Respiratory and Vitamins / Minerals / Nutrients. Its products are sold across various countries, which include United States, Europe, Canada, and others.

Which sector is Gland Pharma Ltd in?

Gland Pharma Ltd is in the Pharmaceuticals sector, Pharmaceuticals & Biotechnology industry.

What are Gland Pharma Ltd's latest annual revenue and profit?

For the year ended Mar 2026: revenue 6430.65 Cr, profit after tax 1027.32 Cr.

What is the promoter holding and pledge in Gland Pharma Ltd?

Promoter holding is 51.83%; pledged shares are 0.00% of the promoter holding.

Which companies are similar to Gland Pharma Ltd?

Companies in the same sector of similar size: IPCA Laboratories Ltd, GlaxoSmithKline Pharmaceuticals Ltd, Ajanta Pharma Ltd, JB Chemicals & Pharmaceuticals Ltd, Emcure Pharmaceuticals Ltd, Wockhardt Ltd.